Home » SOLVAY PHARMACEUTICALS SETTLES LAWSUIT AGAINST PSEUDO-GENERIC TO CREON MINIMICROSPHERES
SOLVAY PHARMACEUTICALS SETTLES LAWSUIT AGAINST PSEUDO-GENERIC TO CREON MINIMICROSPHERES
July 11, 2006
Solvay Pharmaceuticals, Inc. announced today that it has settled a lawsuit filed against Global Pharmaceuticals and Impax Laboratories, Inc. alleging that the companies falsely advertised and marketed their products as generic equivalents to and substitutes for Solvay Pharmaceuticals' CREON MINIMICROSPHERES (Pancrelipase Delayed-release Capsules, USP).
Yahoo Finance (http://biz.yahoo.com/bw/060711/20060711005704.html?.v=1)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct